Sample | Loss of chromosome | Gain of chromosome | Recurrent/De novo | Note | |
---|---|---|---|---|---|
Ipsilateral 2 | First tumour | Â | Â | Likely to be de novo | Â |
Second tumour | 2p, 3p (partial), | 7q, 8q, 10p (partial), 19p | |||
Ipsilateral 6 | First tumour | 3p (partial) | 17q (partial) | Likely to be recurrent | The second tumour still retains the variation of the primary tumour, especially gain of 17q12 (Her2) |
Second tumour | 3p (partial), 4q, 8p, 9p, 10p, 11q, 13, 18 | 1q (partial), 12p, 14p, 17q (partial), 19p | |||
Ipsilateral 11 | First tumour | Â | 5q (partial), 8q (partial), 17q (partial) | Recurrent | Whole genome variation of primary and second tumour overlaid exactly |
Second tumour | Â | 5q (partial), 8q (partial), 17q (partial) | |||
Ipsilateral 12 | First tumour | 6q, 11q, 12q, 13 | 1q, 11p (partial), 12p, 12q (partial), 19 | Likely to be recurrent | Similar overall patterns in chromosome 11, 12 and 19 |
Second tumour | 2q (partial), 3p (partial), 4, 6q, 7q (partial), 11q, 12q, 13 | 1q, 11p (partial), 12p, 12q (partial), 15, 19 | |||
Contralateral 3 | First tumour | 6q, 11q, 18 | 1q, 11p, 17q (partial) | Likely to be de novo | Â |
Second tumour | 6q, 16q, 22 | 1q, 16p, Xq | |||
Contralateral 10 | First tumour | 3p | 6p, 8q | Likely to be recurrent | Similar overall patterns, especially in chromosome 8, 21 and 22 |
Second tumour | Â | 6p, 8q | |||
Contralateral 13 | First tumour | Â | 3p (partial), 8q, 11q (partial) | Likely to be recurrent | Â |
Second tumour | Â | 3p (partial), 8q, 11q (partial) |